Addressing the Public Health Threat of Steatotic Liver Disease in Mexico

Arch Med Res. 2026 Jul 9;57(7):103476. doi: 10.1016/j.arcmed.2026.103476. Online ahead of print.ABSTRACTLiver diseases constitute the fifth leading cause of death in Mexico, and metabolic dysfunction-associated steatotic liver disease (MASLD) is one of the main causes. MASLD, formerly known as non-a

M María Fernanda Bautista Garín

Global prevalence of elevated high-sensitivity C-reactive protein in patients with atherosclerotic cardiovascular disease, with and without chronic kidney disease: findings from the POSEIDON study

Atherosclerosis. 2026 Jun 18;419:120816. doi: 10.1016/j.atherosclerosis.2026.120816. Online ahead of print.ABSTRACTBACKGROUND AND AIMS: Inflammation is a causal risk factor for atherosclerotic cardiovascular disease (ASCVD). Contemporary global data on the prevalence of high inflammatory risk (high-

A Ann Marie Navar

Outcomes after heart valve surgery for adult patients with active Enterococcus faecalis infective endocarditis: a 20-year, national, retrospective, observational cohort study in Aotearoa New Zealand

J Antimicrob Chemother. 2026 Jul 2;81(8):dkag222. doi: 10.1093/jac/dkag222.ABSTRACTBACKGROUND: The post-surgical duration of antibiotic treatment for patients with active infective endocarditis (IE), receiving heart valve surgery is uncertain. We aimed to assess the antibiotic treatment received by,

S Simon Briggs